Atlas Trials

Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic Nephropathy

Clinical trial NCT05695573 · COMPLETED

Trial details

NCT number
NCT05695573
Sponsor
Tanta University
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetic Nephropathy
Start date
2019-07-05
Primary completion
2022-04-28
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.